Alembic Pharma to raise up to Rs 300 crore via NCDs

The board of Alembic Pharmaceuticals has approved raising of up to Rs 300 crore through issuance of non-convertible debentures (NCDs) on a private placement basis. The company will issue NCDs in one or more tranches.

Share this:

Related Post

Stay Updated on Medical Equipment and Devices industry.
Receive our Daily Newsletter.